VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162 | -9.0% | 6 | 0.0% | 0.00% | – |
| Q2 2023 | $178 | -8.7% | 6 | 0.0% | 0.00% | – |
| Q1 2023 | $195 | -99.9% | 6 | -100.0% | 0.00% | -100.0% |
| Q4 2022 | $346,013 | -51.1% | 12,006 | -59.8% | 0.00% | -50.0% |
| Q3 2022 | $708,000 | -16.7% | 29,897 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $850,000 | -63.2% | 29,897 | -50.0% | 0.01% | -54.5% |
| Q1 2022 | $2,312,000 | +143.4% | 59,794 | +100.0% | 0.01% | +120.0% |
| Q4 2021 | $950,000 | +21.2% | 29,897 | +10.2% | 0.01% | +25.0% |
| Q3 2021 | $784,000 | -14.1% | 27,130 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $913,000 | -0.7% | 27,130 | -6.1% | 0.01% | 0.0% |
| Q1 2021 | $919,000 | -20.4% | 28,882 | -8.6% | 0.01% | -28.6% |
| Q4 2020 | $1,155,000 | -0.9% | 31,604 | +6.7% | 0.01% | -12.5% |
| Q3 2020 | $1,166,000 | -11.5% | 29,624 | -20.0% | 0.01% | -27.3% |
| Q2 2020 | $1,317,000 | +44.4% | 37,046 | -2.8% | 0.01% | +22.2% |
| Q1 2020 | $912,000 | -9.5% | 38,109 | +11.5% | 0.01% | +12.5% |
| Q4 2019 | $1,008,000 | +16.4% | 34,169 | +8.3% | 0.01% | +14.3% |
| Q3 2019 | $866,000 | -7.3% | 31,549 | -13.7% | 0.01% | -12.5% |
| Q2 2019 | $934,000 | +76.9% | 36,549 | +55.2% | 0.01% | +60.0% |
| Q1 2019 | $528,000 | +3.9% | 23,549 | -2.3% | 0.01% | 0.0% |
| Q4 2018 | $508,000 | -9.4% | 24,100 | -20.5% | 0.01% | 0.0% |
| Q3 2018 | $561,000 | -56.9% | 30,300 | -48.0% | 0.01% | -58.3% |
| Q2 2018 | $1,301,000 | +157.1% | 58,300 | +153.5% | 0.01% | +140.0% |
| Q1 2018 | $506,000 | -44.9% | 23,000 | -42.5% | 0.01% | -44.4% |
| Q3 2017 | $918,000 | -19.3% | 40,000 | -22.3% | 0.01% | -18.2% |
| Q2 2017 | $1,137,000 | -31.7% | 51,500 | -29.5% | 0.01% | -31.2% |
| Q1 2017 | $1,665,000 | +25.7% | 73,000 | +15.3% | 0.02% | +14.3% |
| Q4 2016 | $1,325,000 | -31.5% | 63,326 | -13.5% | 0.01% | -30.0% |
| Q3 2016 | $1,935,000 | +21.0% | 73,226 | +26.9% | 0.02% | -4.8% |
| Q2 2016 | $1,599,000 | – | 57,726 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |